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Figure S1 Virulence of S. aureus strains displaying altered haemolysis and bacterial numbers 
of the parent strain, in the zebrafish model of infection 
 
a,b, Survival curves of fish injected with S. aureus JE2 (1500 CFU) or S. aureus JE2 mutants 
identified in the Tn library screen showing altered haemolysis on human blood agar. NS, not 
significant. c, Growth of S. aureus SH1000 within embryos after injection with 1500 CFU. Open 
circles, live and filled circles, dead embryos.  
  
Figure S2 The purine de novo biosynthesis pathway 
 
PurB has two roles in the pathway, one before IMP branching and one after branching leading to 
ATP synthesis (1–3). Abbreviations: PRPP, 5-phospho-α-D-ribose 1-diphosphate; PRA, 5-
phospho-β-D-ribosylamine; GAR, N1-(5-phospho-β-D- ribosyl)glycinamide; FGAR, N2-formyl-
N1-(5-phospho-β-D-ribosyl)glycinamide; FGAM, 2-(formamido)-N1-(5-phospho-β-D-
ribosyl)acetamidine; AIR, 5-amino-1-(5- phospho-β-D-ribosyl)imidazole; N5-CAIR, N5-
carboxyaminoimidazole ribonucleotide; CAIR, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-
carboxylate; SAICAIR, 5'- phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole; 
AICAIR, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide; FAICAIR, 5-formamido-
1-(5- phospho-D-ribosyl)-imidazole-4-carboxamide; IMP, inosine monophosphate, Adenylo-
succ, N6-(1,2-dicarboxyethyl)-AMP; AMP, adenosine-monophosphate.  
 
	  
  
Figure S3 The growth of pabA on human blood/blood component agar 
 
Growth of parent (JE2) or pabA on human serum (50% v/v), human plasma (50% v/v) or whole 
human blood (30% v/v) agar. Plates were incubated aerobically at 37°C for 48 h.  
	  
  
Figure S4 The metabolic functions of folate 
 
Enzymes using folate as a cofactor are shown. i, serine/glycine interconversion; ii, vitamin B5 
biosynthesis; iii, synthesis of dTTP from dTMP iv, conversion of 5,10-methylene-THF to 5-
methyl-THF; v, remethylation of L-homocysteine; vi, 10-formyl-THF production from THF; vii, 
use of 10-formyl-THF to formylate L-methionine charged tRNA; viii, 10-formyl-THF-dependent 
conversion of AICAIR to FAICAIR (purine de novo biosynthesis).  
Dashed lines - 1 or more steps not shown. (1) 
	  
  
Figure S5 Role of PabA in the nutritional requirements of S. aureus  
 
a, Growth of S. aureus JE2 and JE2-pabA on human blood agar (30% v/v) either unsupplemented 
or supplemented with PABA (20 µg ml-1) or thymine (400 µg ml-1). b, Growth of S. aureus SH1000 
(1), pabAspc (2), pabAspctdkery (3), pabAspcpdpery (4), or pabAspcnupCery (5) on human blood agar 
(30% v/v) either unsupplemented or supplemented with PABA (20 µg ml-1); thymine (400 µg ml-
1) or thymidine (400 µg ml-1). Key to strain positions is as shown. 
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